LINC01123
gene geneOn this page
Also known as YG-6
Summary
LINC01123 (long intergenic non-protein coding RNA 1123, HGNC:49269) is a long non-coding RNA gene on chromosome 2q13.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:49269 |
| Approved symbol | LINC01123 |
| Name | long intergenic non-protein coding RNA 1123 |
| Location | 2q13 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | YG-6 |
| Ensembl gene | ENSG00000204588 |
| Ensembl biotype | lncRNA |
| Entrez | 440894 |
| RNAcentral | URS000075DA1D — lncRNA, 2519 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 7 lncRNA
ENST00000336905, ENST00000419296, ENST00000767830, ENST00000767831, ENST00000767832, ENST00000767833, ENST00000767834
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000336905 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001256270 | 109988272 | 109988802 |
| ENSE00001628801 | 109994401 | 109996140 |
Expression profiles
Bgee: expression breadth ubiquitous, 126 present calls, max score 95.14.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1215 / max 5.9754, expressed in 69 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 21929 | 0.1215 | 69 |
Top tissues by expression
126 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primary visual cortex | UBERON:0002436 | 95.14 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 94.66 | gold quality |
| prefrontal cortex | UBERON:0000451 | 90.96 | gold quality |
| frontal cortex | UBERON:0001870 | 89.91 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 89.61 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 89.36 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 88.40 | gold quality |
| right frontal lobe | UBERON:0002810 | 88.26 | gold quality |
| cerebral cortex | UBERON:0000956 | 87.44 | gold quality |
| nucleus accumbens | UBERON:0001882 | 85.76 | gold quality |
| body of pancreas | UBERON:0001150 | 85.61 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 85.46 | gold quality |
| putamen | UBERON:0001874 | 82.73 | gold quality |
| metanephros cortex | UBERON:0010533 | 81.94 | gold quality |
| caudate nucleus | UBERON:0001873 | 81.71 | gold quality |
| pancreas | UBERON:0001264 | 80.52 | gold quality |
| brain | UBERON:0000955 | 80.30 | gold quality |
| hypothalamus | UBERON:0001898 | 79.14 | gold quality |
| Ammon’s horn | UBERON:0001954 | 78.95 | gold quality |
| duodenum | UBERON:0002114 | 78.93 | gold quality |
| cortex of kidney | UBERON:0001225 | 78.91 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 78.84 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 78.62 | gold quality |
| ascending aorta | UBERON:0001496 | 78.15 | gold quality |
| small intestine | UBERON:0002108 | 78.08 | gold quality |
| temporal lobe | UBERON:0001871 | 78.03 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 78.00 | gold quality |
| thoracic aorta | UBERON:0001515 | 77.93 | gold quality |
| amygdala | UBERON:0001876 | 77.82 | gold quality |
| thyroid gland | UBERON:0002046 | 77.82 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.49 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 10)
- Functional assays showed that LINC01123 promoted NSCLC cell proliferation and aerobic glycolysis. Mechanistic investigations revealed that LINC01123 was a direct transcriptional target of c-Myc. LINC01123 increased c-Myc mRNA expression by sponging miR-199a-5p. (PMID:31488218)
- LINC01123 facilitates proliferation, invasion and chemoresistance of colon cancer cells. (PMID:32700743)
- ZEB1-activated LINC01123 accelerates the malignancy in lung adenocarcinoma through NOTCH signaling pathway. (PMID:33191397)
- LINC01123 enhances osteosarcoma cell growth by activating the Hedgehog pathway via the miR-516b-5p/Gli1 axis. (PMID:33837611)
- LINC01123 promotes cell proliferation and migration via regulating miR-1277-5p/KLF5 axis in ox-LDL-induced vascular smooth muscle cells. (PMID:34403009)
- LINC01123 is associated with prognosis of oral squamous cell carcinoma and involved in tumor progression by sponging miR-34a-5p. (PMID:34511356)
- LINC01123 potentially correlates with radioresistance in glioma through the miR-151a/CENPB axis. (PMID:34519373)
- LINC01123 promotes immune escape by sponging miR-214-3p to regulate B7-H3 in head and neck squamous-cell carcinoma. (PMID:35115487)
- Long non-coding RNA LINC01123 promotes cell proliferation, migration and invasion via interacting with SRSF7 in colorectal cancer. (PMID:35325644)
- LINC01123 acts as an oncogenic driver in lung adenocarcinoma by regulating the miR-4766-5p/PYCR1 axis. (PMID:36994814)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.